Ascendis Pharma Other Long Term Liabilities (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

217.73 +2.68 (+1.25%) USD | NASDAQ | Jan 14, 12:40

View Other Long Term Liabilities (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	Upgrade
Evaxion AS	--
DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade